Brian Rosenberger

 

Brian Rosenberger currently serves as the Senior Vice President of Business Development at Nuvie Bio.

 

Brian has over 30 years of industry experience in leadership roles in marketing, sales, business development, analytics, and alliance management.

 

Most recently, he was a member of the executive management team at Zynerba Pharmaceuticals, a clinical-stage biotech company focused on rare CNS disorders, serving as Vice President of Commercial and Business Development until its acquisition by Harmony Biosciences.

 

Prior to Zynerba, Brian was Vice President, Alliance & Strategic Portfolio Management at Cipher Pharmaceuticals, which was preceded by various roles of increasing responsibility at Auxilium Pharmaceuticals, where he contributed to several transformational M&A, licensing and co-promotion deals, including the acquisition by Endo International.

 

Brian also played a key role in the initial commercial build-out at Neurocrine Biosciences and spent over a decade at GlaxoSmithKline in various US and global commercial roles.

 

Brian received a B.A. double major in Political Science/Policy and Management Studies from Dickinson College in Carlisle, PA.